Cart
sales@molnova.com
MCC 555
CAS No. 161600-01-7
MCC 555( Isaglitazone | Netoglitazone | RWJ 241947 )
Catalog No. M12353 CAS No. 161600-01-7
MCC 555 (Isaglitazone;Netoglitazone;RWJ 241947) is an activating ligand of PPARγ with EC50 of 8 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 58 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 214 | Get Quote |
|
| 50MG | 356 | Get Quote |
|
| 100MG | 530 | Get Quote |
|
| 500MG | 1152 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMCC 555
-
NoteResearch use only, not for human use.
-
Brief DescriptionMCC 555 (Isaglitazone;Netoglitazone;RWJ 241947) is an activating ligand of PPARγ with EC50 of 8 uM.
-
DescriptionMCC 555 (Isaglitazone;Netoglitazone;RWJ 241947) is an activating ligand of PPARγ with EC50 of 8 uM, exhibts greater antidiabetic potency that other TZDs including BRL49653; profoundly suppresses growth of PC-3 prostate cancer xenografts with prominent apoptosis, as well as fibrosis, including inflammatory and giant cell reaction in the remaining tumor tissue.Diabetes Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsIsaglitazone | Netoglitazone | RWJ 241947
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number161600-01-7
-
Formula Weight381.421
-
Molecular FormulaC21H16FNO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (655.45 mM)
-
SMILESO=C(N1)SC(CC2=CC=C3C=C(OCC4=CC=CC=C4F)C=CC3=C2)C1=O
-
Chemical Name5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-thiazolidinedione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Reginato MJ, et al. J Biol Chem. 1998 Dec 4;273(49):32679-84.
2. Kumagai T, et al. Clin Cancer Res. 2004 Feb 15;10(4):1508-20.
3. Cekanova M, et al. Eur J Pharmacol. 2010 Jul 10;637(1-3):30-7.
molnova catalog
related products
-
Saroglitazar
A novel PPAR agonist with predominant PPARα and moderate PPARγ activity with EC50 of 0.65 pM and 3 nM respectively.
-
Bezafibrate
Bezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.
-
GW 6471
GW6471 is an antagonist of PPARα with IC50 of 0.24 μ M. GW6471 enhances the binding affinity of the PPAR α ligand-binding domain to the co-repressor proteins SMRT and NCoR.A specific PPARα antagonist.
